Publications by authors named "Lisa D MacDonald"

Claim this Profile
M
Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II Trial.
Oliver Dorigo, Amit M Oza, Tanja Pejovic, Prafull Ghatage, Sharad Ghamande, Lisa D MacDonald

Clin Cancer Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal spore inhalation challenge.
Genevieve M Weir, Lisa D MacDonald, Rajkannan Rajagopalan, Gloria S Sivko, Michelle W Valderas

NPJ Vaccines· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study.
Joanne M Langley, Lisa D MacDonald, Genevieve M Weir, Donna MacKinnon-Cameron, Lingyun Ye

J Infect Dis· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type III hypersensitivity reactions to a B cell epitope antigen are abrogated using a depot forming vaccine platform.
Lisa D MacDonald, Alecia MacKay, Valarmathy Kaliaperumal, Genevieve Weir, Andrea Penwell

Hum Vaccin Immunother· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients.
Neil L Berinstein, Mohan Karkada, Amit M Oza, Kunle Odunsi, Jeannine A Villella, Lisa D MacDonald

Oncoimmunology· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients.
Neil L Berinstein, Mohan Karkada, Michael A Morse, John J Nemunaitis, Gurkamal Chatta, Lisa D MacDonald

J Transl Med· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a single dose hepatitis B depot vaccine.
Lisa D MacDonald, Antar Fuentes-Ortega, Leeladhar Sammatur, Marc Mansour

Vaccine· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel breast/ovarian cancer peptide vaccine platform that promotes specific type-1 but not Treg/Tr1-type responses.
Mohan Karkada, Genevieve M Weir, Tara Quinton, Leeladhar Sammatur, Lisa D MacDonald

J Immunother· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A C-terminal glycine suppresses production of pleurocidin as a fusion peptide in Escherichia coli.
Brian C Bryksa, Lisa D MacDonald, Aleks Patrzykat, Susan E Douglas, Neil R Mattatall

Protein Expr Purif· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis